Presently, the evaluation of PD-L1 positivity by conventional immunohistochemistry is not well defined.22 Therefore, the correlation between miR-197 and PD-L1 also suggests that miR-197 expression can act as a surrogate biomarker of PD-L1 in NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.